Compare EMN & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMN | RDNT |
|---|---|---|
| Founded | 1920 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.7B |
| IPO Year | 1993 | 1986 |
| Metric | EMN | RDNT |
|---|---|---|
| Price | $78.44 | $69.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $78.21 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 1.9M | 722.1K |
| Earning Date | 01-29-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.10 | N/A |
| Revenue | ★ $8,752,000,000.00 | $1,969,599,000.00 |
| Revenue This Year | $1.78 | $11.82 |
| Revenue Next Year | $3.35 | $11.83 |
| P/E Ratio | $18.89 | ★ N/A |
| Revenue Growth | N/A | ★ 11.09 |
| 52 Week Low | $56.11 | $45.00 |
| 52 Week High | $103.82 | $85.84 |
| Indicator | EMN | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 73.38 | 43.56 |
| Support Level | $75.08 | $63.99 |
| Resistance Level | $79.31 | $72.75 |
| Average True Range (ATR) | 2.54 | 2.98 |
| MACD | 0.82 | -0.30 |
| Stochastic Oscillator | 94.15 | 47.46 |
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.